Commentary
“The frequency and impact of pandemic-prone pathogens are increasing. Modest investments in PPR capacities can prevent and contain disease outbreaks, thereby drastically reducing the cost of response.”
Stu Porter/Shutterstock
David Bell
Author
David Bell, senior scholar at the Brownstone Institute, is a public health physician and biotech consultant in global health. He is a former medical officer and scientist at the World Health Organization (WHO), programme head for malaria and febrile diseases at the Foundation for Innovative New Diagnostics (FIND) in Geneva, Switzerland, and director of Global Health Technologies at Intellectual Ventures Global Good Fund in Bellevue, Wash.
